Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
A New Era in Myeloma: An Interview with Elena Zamagni
5
Mins
July 2025
In the beginning, when I was very young, I was more interested in acute leukaemia and the suffering of young people. When I got to…
Read more
11
Mins
14 Sep 2023
Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
This continuing medical education-accredited symposium, held at the 2023 International Society for Thrombosis and Haemostasis (ISTH)…
7
Mins
1 Aug 2023
Expert Insights: Phase III Clinical Trials in Non-Transfusion-Dependent (ENERGIZE) and Transfusion-Dependent (ENERGIZE-T) α- and β-Thalassaemia
The thalassaemias are a heterogeneous group of inherited chronic blood disorders associated with impaired haemoglobin (Hb) synthesis…
9
Mins
1 Aug 2023
What to Do When Chimeric Antigen Receptor T Cells Are Not the Most Appropriate Option in Second-Line Diffuse Large B Cell Lymphoma: Current Treatment Options for Transplant-Ineligible Patients
DLBCL accounts for approximately 30% of non-Hodgkin’s lymphomas diagnosed each year. Initially, DLBCL is generally treated…
8
Mins
20 Jul 2023
Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
The overarching message from the symposium was that diagnosis of SM-AHN is challenging, and SM is often missed in patients with a myeloid…
8
Mins
20 Jul 2023
Steroid Toxicity in Immune Thrombocytopaenia
This article summarises the occurrence of very unusual and rare steroid-related toxicity. It is a cautionary tale of modern medicine where the treatment-related adverse events are more atrocious than the primary disease.
5
Mins
30 May 2023
Interview: Janis Abkowitz
Janis Abkowitz | Head, Division of Hematology, University of Washington, Seattle, USA; Adjunct Professor of Genome Sciences, University of…
6
Mins
19 May 2023
Interview: Cynthia Dunbar
Cynthia Dunbar – Secretary, American Society of Hematology (ASH); Chief, Translational Stem Cell Biology Branch, and Head, Molecular…
11
Mins
15 Feb 2023
Realising the Promise of Gene Therapy for Haemophilia: Current Status and Future Innovations
Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.
Loading posts...
« Previous
1
2
3
4
5
6
…
23
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View